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Atypical Primary Epithelioid Hemangioendothelioma
of the Heart
N. Moulai, MD,* O. Chavanon, MD, PhD,† L. Guillou, MD, PhD,‡ M. Noirclerc, MD,†
D. Blin, MD,† E. Brambilla, MD,* and S. Lantuejoul, MD, PhD*
We report an unusual case of primary cardiac epithelioid heman-
gioendothelioma (EHE) with atypical features, which was treated by
orthoptic transplantation with a good outcome for 10 years despite
recurrent pulmonary and nodal metastases. EHE is a rare vascular
tumor that belongs to the group of malignant proliferations from the
new World Health Organization classification of soft tissue tumors.
EHE may harbor atypical features that confer a more aggressive
course, albeit better than that of conventional angiosarcomas. His-
tological examination of the primary cardiac tumor revealed a
proliferation of large epithelioid tumor cells presenting atypical
features and a mitotic index of 3 mitoses per 10 high power fields.
In contrast, pulmonary metastases exhibited typical features of EHE,
and CD 34 and CD 31 immunostainings strongly stained cytoplas-
mic vascular lumen. In this report, we illustrate the potential aggres-
siveness of the atypical variant of EHE and suggest that transplan-
tation might be considered as an alternative therapy in the treatment
of EHE of the heart.
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Although previously considered as a borderline or a low-grade malignant vascular lesion, epithelioid hemangioen-
dothelioma (EHE) is regarded in the recent World Health
Organization classification1 as a malignant tumor along with
angiosarcomas, because of its local aggressiveness and its
metastasizing potential. Nearly 15% of EHE exhibit atypical
histological features suggesting more aggressive behavior.2
Only five cases have been described in the heart;3 we report
the first case of an atypical primary cardiac EHE treated by
orthoptic transplantation with a good clinical outcome for 10
years despite recurrent metastases.
CASE REPORT
A 53-year-old man was admitted for a cardiac mass
invading the coronary sinus, the endocardium, and the epi-
cardium. The surgical biopsy at histological examination
showed large epithelioid tumor cells isolated in a myxo-
hyaline stroma and presenting with atypical features and a
high mitotic index of 3 mitoses per 10 HPF (Figure 1).
Although tumor cells were negative with all antibodies used
(CD 34 and CD31 antibodies being unavailable to us at that
time), a diagnosis of poorly differentiated sarcoma with
epithelioid features of grade III (in accordance with the
National Cancer Institute grading system) was proposed. As
chemotherapy combining doxorubicin and ifosfamide was
ineffective, the patient underwent a cardiac transplantation.
Two years later, he developed a pulmonary nodule, which on
open lung biopsy demonstrated classical histological features
of EHE, with plump epithelioid cells typically extending in a
polypoid pattern into bronchioloalveolar lumens at the pe-
riphery of a sclerotic core (Figure 2). Cytoplasms contained
erythrocytes within small intracytoplasmic lumina (Figure
3A). All immunostainings were negative except with CD 34
and CD 31 antibodies, which strongly stained the cytoplasmic
vascular lumen (Figure 3B). Despite the occurrence of 10
pulmonary and nodal metastases, the patient is still alive and
well 10 years after his transplantation.
DISCUSSION
Primary cardiac tumors are very rare, with only a few
cases of primary cardiac EHE reported.3 According to
Mentzel et al.,2 EHE may exhibit nuclear atypia, solid angio-
sarcoma-like foci, and a mitotic index higher than 2 mitoses
per 10 HPF, justifying their designation as “malignant EHE”
even if their metastatic rate and mortality rates are lower than
those of conventional angiosarcomas. Histologically, EHE
differ from angiosarcomas by their lack of necrosis and
angiocentricity, whereas mitoses and atypia are against an
epithelioid hemangioma, which rarely occurs in the heart.
The expression of vascular endothelial markers such as von
Willebrand factor, CD 31, and CD34, rules out metastatic
adenocarcinoma or melanoma.
When considering all sites of EHE, local recurrence of
EHE and metastases occur in less than 15% and 30% of
cases, respectively, and mortality varies from 10 to 20%.
These data are likely influenced by the inclusion of both
classical and atypical cases. There is no standard therapy for
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EHE, although remissions with chemotherapy have been
reported.4 In this report, we illustrate the potential aggres-
siveness of an atypical variant of EHE and suggest that when
chemotherapy is ineffective, transplantation hepatic EHE
should may represent an alternative therapy in cardiac EHE.
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FIGURE 1. Histological examination of the primary cardiac
tumor revealed a proliferation of large epithelioid tumor cells
presenting atypical features (arrow). Hematoxylin-eosin-saf-
fron staining; original magnification 400.
FIGURE 2. Pulmonary metastasis corresponding to a classi-
cal nodular lesion, with a hypocellular fibrotic center and a
more cellular periphery, composed of tumor cells that typi-
cally spread into the bronchioloalveolar lumen in a polypoid
fashion. Hematoxylin-eosin-saffron staining; original magnifi-
cation 200.
FIGURE 3. A, At higher magnification, epithelioid tumor
cells harbor regular nuclei and large vacuolated cytoplasms
containing rare red blood cells (arrow). Hematoxylin-eosin-
saffron staining; original magnification 400. B, CD 34 im-
munostaining enlightening primitive intracellular vascular
channels (arrow). Immunoperoxidase staining; original mag-
nification 400.
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